SEC Form 4 · accession 0001654954-19-001667
AYTU BIOPHARMA, INC · AYTU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Green
Officer — Chief Financial Officer
Period of report
Feb 13, 2019
Accepted (ET)
Feb 15, 2019 · 4:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385818
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 13, 2019 | A | 3,500 | $1.039 | A | 269,750 | D | |
| Common Stock | Feb 13, 2019 | A | 1,500 | $1.035 | A | 271,250 | D |
Table II — derivative securities
No Table II lines on this filing.